Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial

Objectives To determine whether use of the Screening Tool of Older Persons' Prescriptions (STOPP) and Screening Tool to Alert to Right Treatment (START) criteria reduces incident hospital‐acquired adverse drug reactions (ADRs), 28‐day medication costs, and median length of hospital stay in olde...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of the American Geriatrics Society (JAGS) Ročník 64; číslo 8; s. 1558 - 1566
Hlavní autoři: O'Connor, Marie N., O'Sullivan, David, Gallagher, Paul F., Eustace, Joseph, Byrne, Stephen, O'Mahony, Denis
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Blackwell Publishing Ltd 01.08.2016
Wiley Subscription Services, Inc
Témata:
ISSN:0002-8614, 1532-5415
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Objectives To determine whether use of the Screening Tool of Older Persons' Prescriptions (STOPP) and Screening Tool to Alert to Right Treatment (START) criteria reduces incident hospital‐acquired adverse drug reactions (ADRs), 28‐day medication costs, and median length of hospital stay in older adults admitted with acute illness. Design Single‐blind cluster randomized controlled trial (RCT) of unselected older adults hospitalized over a 13‐month period. Setting Tertiary referral hospital in southern Ireland. Participants Consecutively admitted individuals aged 65 and older (N = 732). Intervention Single time point presentation to attending physicians of potentially inappropriate medications according to the STOPP/START criteria. Measurements The primary outcome was the proportion of participants experiencing one or more ADRs during the index hospitalization. Secondary outcomes were median length of stay (LOS) and 28‐day total medication cost. Results One or more ADRs occurred in 78 of the 372 control participants (21.0%; median age 78, interquartile range (IQR) 72–84) and in 42 of the 360 intervention participants (11.7%; median age 80, IQR 73–85) (absolute risk reduction = 9.3%, number needed to treat = 11). The median LOS in the hospital was 8 days (IQR 4–14 days) in both groups. At discharge, median medication cost was significantly lower in the intervention group (€73.16, IQR €38.68–121.72) than in the control group (€90.62, IQR €49.38–162.53) (Wilcoxon rank test Z statistic = −3.274, P < .001). Conclusion Application of STOPP/START criteria resulted in significant reductions in ADR incidence and medication costs in acutely ill older adults but did not affect median LOS.
Bibliografie:ark:/67375/WNG-8D5HRF14-F
Table S1. Diagnostic profiles of the control and intervention groups. Table S2. Frequency of potentially inappropriate prescriptions in the intervention group.
Health Research Board of Ireland - No. HRA_HSR/2010/14
ArticleID:JGS14312
istex:6093B8E7CE0B47269B444E34C6368DCFFBE606B0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0002-8614
1532-5415
DOI:10.1111/jgs.14312